New York, Sep 21 (IANS): The US’ National Institutes of Health (NIH) has announced the launch of Phase 1 clinical trial of a preventive HIV vaccine.   The novel vaccine, VIR-1388, is known for its safety and ability to induce an HIV-specific immune response …